Skip to main content
Top
Published in: Drugs & Aging 11/2002

01-11-2002 | Original Research Article

Potential Interactions between Herbal Medicines and Conventional Drug Therapies Used by Older Adults Attending a Memory Clinic

Authors: Ms Julie M. Dergal, Jennifer L. Gold, Dara A. Laxer, Monica S. W. Lee, Malcolm A. Binns, Krista L. Lanctôt, Morris Freedman, Paula A. Rochon

Published in: Drugs & Aging | Issue 11/2002

Login to get access

Abstract

Objective

Herbal medicines and conventional drug therapies are often taken in combination. The objective of our study was to identify the range of natural health products and conventional drug therapies used by older adults (aged 65 years and over) attending a memory clinic, and to specifically evaluate the frequency of potential interactions between herbal medicines and conventional drug therapies.

Design

We interviewed consecutive patients attending the Memory Disorders Clinic at the Baycrest Centre for Geriatric Care, a University of Toronto teaching hospital, between 4 July and 15 August 2000. Patients were asked to bring to their appointment all natural health products (i.e. herbal medicines, vitamins and minerals) and conventional drug therapies (i.e. prescription and over-the-counter) they were currently using. We collected information on current and previously used natural health products and current conventional drug therapies. Patients were classified as having the potential for an interaction if they were using a current herbal medicine in combination with a conventional drug therapy and the interaction had been reported previously in the medical literature.

Participants

We interviewed 195 consecutive patients attending the Memory Disorders Clinic at the Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada.

Results

Of the 195 patients in our sample, 33 (17%) were ‘current users’, 19 (10%) were ‘past users’, and 143 (73%) were ‘never users’ of herbal medicines. Among the 52 patients who were ‘current or past users’, the most frequently used herbal medicines were ginkgo (Ginkgo biloba) [39 users], garlic (n = 10), glucosamine sulphate (n = 9) and echinacea (n = 8). Among the 33 patients who were current users, the most commonly used herbal medicines were Ginkgo biloba (n = 22), glucosamine sulphate (n = 8) and garlic (n = 6). Among the 33 current users, we identified 11 potential herb-drug interactions in nine patients. The 11 herb-drug interactions we identified were between ginkgo and aspirin (acetylsalicylic acid) [n = 8], ginkgo and trazodone (n = 1), ginseng and amlodipine (n = 1) and valerian and lorazepam (n = 1).

Conclusions

Herbal medicines are widely used. Almost one-third of current users of herbal medicines were at risk of a herb-drug interaction. The most common potential herb-drug interaction was between ginkgo and aspirin. This finding has important potential implications because both of these products are regularly used by older people. Physicians and other healthcare providers should be aware of potential herb-drug interactions and should monitor and inform their patients accordingly.
Literature
1.
go back to reference Eisenberg D, Davis R, Ettner S, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280(18): 1569–75PubMedCrossRef Eisenberg D, Davis R, Ettner S, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280(18): 1569–75PubMedCrossRef
2.
go back to reference Cupp M. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59: 1239–45PubMed Cupp M. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59: 1239–45PubMed
3.
go back to reference Gold JL, Laxer DA, Dergal JM, et al. Interactions between herbal and conventional drug therapy: a focus on dementia. Curr Opin Clin Nutr Metab Care 2001; 4(1): 29–34PubMedCrossRef Gold JL, Laxer DA, Dergal JM, et al. Interactions between herbal and conventional drug therapy: a focus on dementia. Curr Opin Clin Nutr Metab Care 2001; 4(1): 29–34PubMedCrossRef
4.
go back to reference Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61(15): 2163–75PubMedCrossRef Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61(15): 2163–75PubMedCrossRef
5.
go back to reference Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136(1): 42–53PubMed Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136(1): 42–53PubMed
6.
go back to reference Edwards R. WHO project is under way. BMJ 1995; (311): 1569–70 Edwards R. WHO project is under way. BMJ 1995; (311): 1569–70
8.
go back to reference Health Canada. Final report of the advisory panel on natural health products: regulatory framework for natural health products. Report: Health Canada; 1998 May 13 Health Canada. Final report of the advisory panel on natural health products: regulatory framework for natural health products. Report: Health Canada; 1998 May 13
9.
go back to reference Chandler F. Herbs: an everyday reference for health professionals. Nepan, Ontario: Canadian Pharmacists Association and Canadian Medical Association, 2000 Chandler F. Herbs: an everyday reference for health professionals. Nepan, Ontario: Canadian Pharmacists Association and Canadian Medical Association, 2000
10.
go back to reference Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract [letter]. N Engl J Med 1997; 336: 1108PubMedCrossRef Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract [letter]. N Engl J Med 1997; 336: 1108PubMedCrossRef
11.
go back to reference Galluzzi S, Zanetti O, Binetti G, et al. Coma in a patient with Alzheimer’s disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68: 679–83PubMedCrossRef Galluzzi S, Zanetti O, Binetti G, et al. Coma in a patient with Alzheimer’s disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68: 679–83PubMedCrossRef
12.
go back to reference Becker BN, Greene J, Evanson J, et al. Ginseng-induced diuretic resistance. JAMA 1996; 276: 606–7PubMedCrossRef Becker BN, Greene J, Evanson J, et al. Ginseng-induced diuretic resistance. JAMA 1996; 276: 606–7PubMedCrossRef
13.
go back to reference Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health care professionals. London: Pharmaceutical Press, 1996 Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health care professionals. London: Pharmaceutical Press, 1996
14.
go back to reference Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer’s disease. J Am Geriatr Soc 1995; 43: 747–50PubMed Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer’s disease. J Am Geriatr Soc 1995; 43: 747–50PubMed
15.
go back to reference Hogan D, Ebly E. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord 1996; 10(2): 63–7PubMedCrossRef Hogan D, Ebly E. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord 1996; 10(2): 63–7PubMedCrossRef
16.
go back to reference Gold JL, Laxer DA, Rochon PA. Herbal remedies: a critical perspective [letter]. Ann R Coll Physicians Surg Can 2000; 33: 497 Gold JL, Laxer DA, Rochon PA. Herbal remedies: a critical perspective [letter]. Ann R Coll Physicians Surg Can 2000; 33: 497
18.
go back to reference Klepser TB, Doucette WR, Horton MR, et al. Assessment of patients’ perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000; 20(1): 83–7PubMedCrossRef Klepser TB, Doucette WR, Horton MR, et al. Assessment of patients’ perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000; 20(1): 83–7PubMedCrossRef
19.
go back to reference Barnes J, Mills SY, Abbot NC, et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496–500PubMedCrossRef Barnes J, Mills SY, Abbot NC, et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496–500PubMedCrossRef
Metadata
Title
Potential Interactions between Herbal Medicines and Conventional Drug Therapies Used by Older Adults Attending a Memory Clinic
Authors
Ms Julie M. Dergal
Jennifer L. Gold
Dara A. Laxer
Monica S. W. Lee
Malcolm A. Binns
Krista L. Lanctôt
Morris Freedman
Paula A. Rochon
Publication date
01-11-2002
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 11/2002
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200219110-00005

Other articles of this Issue 11/2002

Drugs & Aging 11/2002 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.